Serum concentrations of GM-CSF and G-CSF correlate with the Th1/Th2 cytokine response in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection

APMIS

Volumn 113, Issue 6, 2005, Pages 400-409

  Moser, Claus ^a   Jensen, Peter Ø ^a   Pressler, Tacjana ^a   Frederiksen, Birgitte ^a   Lanng, Susanne ^a   Kharazmi, Arsalan ^a   Koch, Christian ^a   Høiby, Niels ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Cystic fibrosis; G CSF; GM CSF; Pseudomonas aeruginosa; Th1 Th2 response

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; INTERLEUKIN 4; NONSTEROID ANTIINFLAMMATORY AGENT;

ADOLESCENT; ADULT; ANTIBODY PRODUCTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INFLAMMATION; LUNG FUNCTION; LUNG INFECTION; MALE; MONOCYTE; NEUTROPHIL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SERUM; TH1 CELL; TH2 CELL;

ADOLESCENT; ADULT; CHRONIC DISEASE; CYSTIC FIBROSIS; CYTOKINES; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; MALE; PNEUMONIA, BACTERIAL; PROGNOSIS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; TH1 CELLS; TH2 CELLS;

EID: 22044442105     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2005.apm_142.x     Document Type: Article

References (57)

1. Koch C, Hoiby N. Pathogenesis of cystic fibrosis. Lancet 1993;341:1065-9.
2. Pedersen SS, Hoiby N, Espersen F, Koch C. Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis. Thorax 1992;47: 6-13.
3. Mathee K, Ciofu O, Sternberg C, Lindum PW, Cambell JIA, Jensen P, et al. Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung. Microbiology 1999;145: 1349-57.
4. Hoiby N, Flensborg EW, Beck B, Friis B, Jacobsen SV, Jacobsen L. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. Scand J Resp Dis 1977;58:65-79.
5. Sorensen RU, Stern RC, Polmar SH. Cellular immunity to bacteria: impairment of in vitro lymphocyte response to Pseudomonas aeruginosa in cystic fibrosis patients. Infect Immun 1977;18: 735-40.
6. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136:2348-57.
7. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996;383: 787-93.
8. Lucey DR, Clerici M, Shearer GM. Type 1 and Type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin Microbiol Rev 1996;9:532-62.
9. Kemp M, Theander TG, Kharazmi A. The contrasting roles of CD4+ cells in intracellular infections in humans: leishmaniasis as an example. Immunol Today 1996;17:13-6.
10. Moser C, Kjaergaard S, Pressler T, Kharazmi A, Koch C, Hoiby N. The immune response to chronic Pseudomonas aeruginosa lung infection in cystic fibrosis patients is predominantly of the Th2 type. APMIS 2000;108:329-35.
11. Moss RB, Hsu YP, Olds L. Cytokine dysregulation in activated cystic fibrosis (CF) peripheral lymphocytes. Clin Exp Immunol 2000;120:518-25.
12. Wojnarowski C, Frischer T, Hofbauer E, Grabner C, Mosgoeller W, Eichler I, et al. Cytokine expression in bronchial biopsies of cystic fibrosis patients with and without acute exacerbation. Eur Respir J 1999;14:1136-44.
13. Markham RB, Powderley WG. Exposure of mice to live Pseudomonas aeruginosa generates protective cell-mediated immunity in the absence of an antibody response. J Immunol 1988;140:2039-45.
14. Powderley WG, Pier GP, Markham RB. T lymphocyte-mediated protection against Pseudomonas aeruginosa infection in granulocytopenic mice. J Clin Invest 1986;78:375-80.
15. Markham RB, Pier GP, Powderley WG. Suppressor T cells regulating the cell-mediated immune response to Pseudomonas aeruginosa can be generated by immunization with anti-bacterial T cells. J Immunol 1988;141:3975-9.
16. Dunkley ML, Clancey RL, Cripps AW. A role for CD4+ T cells from orally immunized rats in enhanced clearance of Pseudomonas aeruginosa from the lung. Immunology 1994;83:362-9.
17. Moser C, Johansen HK, Song Z, Hougen HP, Rygaard J, Hoiby N. Chronic Pseudomonas aeruginosa lung infection is more severe in Th2 responding BALB/c mice compared to Th1 responding C3H/HeN mice. APMIS 1997;105:838-42.
18. Moser C, Hougen HP, Song Z, Rygaard J, Kharazmi A, Hoiby N. Early immune response in susceptible and resistant mice strains with chronic Pseudomonas aeruginosa lung infection determines the type of T-helper cell response. APMIS 1999;107:1093-100.
19. Moser C, Jensen PØ, Kobayashi O, Hougen HP, Song Z, Rygaard J, et al. Improved outcome of chronic Pseudomonas aeruginosa lung infection is associated with induction of a Th1 dominated cytokine response. Clin Exp Immunol 2002;127: 206-13.
20. Johansen HK, Hougen HP, Rygaard J, Hoiby. Interferon-gamma (IFN-γ) treatment decreases the inflammatory response in chronic Pseudomonas aeruginosa pneumonia in rats. Clin Exp Immunol 1996;103:212-8.
21. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-52.
22. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991;9:271-96.
23. Metlay JP, Witmer-Pack MD, Agger R, Crowley MT, Lawless D, Steinman RM. The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies. J Exp Med 1990;171:1753-71.
24. Austyn JM. New insights into the mobilization and phagocytic activity of dendritic cells. J Exp Med 1996;183:1287-92.
25. Rissoan M-C, Soumelis V, Kadowaki N, Grouard G, Briere F, Malefyt RW, et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science 1999;283:1183-6.
26. Pulendran B, Smith JL, Caspary G, Brasel K, Petit D, Maraskovsky E, et al. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc Natl Acad Sci USA 1999;96:1036-41.
27. Pulendran B, Maraskovsky E, Banchereau J, Maliszewski C. Modulating the immune response with dendritic cells and their growth factors. Trends Immunol 2001;22:41-7.
28. Arpinati M, Green CL, Heimfeld S, Heuser JE, Anasetti C. Granulocyte-colony stimulating factor mobilizes T helper 2-induced dendritic cells. Blood 2000;95:2484-90.
29. + peripheral blood dendritic cells are differentially regulated by cytokines. J Immunol 1999;163:3250-9.
30. Pulendran B, Banchereau J, Burkeholder S, Kraus E, Guinet E, Chalouni C, et al. Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo. J Immunol 2000;165:566-72.
31. Reibman J, Talbot AT, Hsu Y, Ou G, Jover J, Nilsen D, et al. Regulation of expression of granulocyte-macrophage colony-stimulating factor in human bronchial epithelial cells: roles of protein kinase C and mitogen-activated protein kinases. J Immunol 2000;165:1618-25.
32. Plaut M, Pierce JH, Watson CJ, Hanley-Hyde J, Nordan RP, Paul WE. Mast cell lines produce lymphokines in response to cross-linkage of FcεRIor to calcium ionophores. Nature 1989;339:64-7.
33. Rich IN. A role for the macrophage in normal hemopoiesis. I. Functional capacity of bone-marrow-derived macrophages to release hemopoietic growth factors. Exp Hematology 1986;14: 738-45.
34. Quesenberry PJ, Gimbrone MA. Vascular endothelium as a regulator of granulopoiesis: production of colony-stimulating activity by cultured human endothelial cells. Blood 1980;56:1060-7.
35. Koeffler HP, Gasson J, Ranyard J, Souza L, Shepard M, Munker R. Recombinant human TNF-α stimulates production of granulocyte colony-stimulating factor. Blood 1987;70:55-9.
36. Metcalf D, Nicola NA. Synthesis by mouse peritoneal cells of G-CSF, the differentiation inducer for myeloid leukemia cells: stimulation by endotoxin, M-CSF and multi-CSF. Leuk Res 1985;1: 35-50.
37. Broudy VC, Kaushansky K, Harlan JM, Adamson JW. Interleukin 1 stimulates human endothelial cells to produce granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor. J Immunol 1987;139:464-8.
38. Hoiby N. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. A survey. Acta path microbiol scand Sect C 1977;(Suppl 262):3-96.
39. Cicala C, Ianaro A, Fiorucci S, Calignano A, Bucci M, Gerli R, et al. NO-naproxen modulates inflammation, nociception and downregulates T cell response in rat Freund's adjuvant arthritis. Br J Pharmacol 2000;130:1399-405.
40. Sirota L, Punsky I, Bessler H. Effect of indomethacin on IL-1beta, IL-6 and TNFalpha production by mononuclear cells of preterm newborns and adults. Acta Paediatr 2000;89:331-5.
41. Kleinjan A, Holm AF, Dijkstra MD, Boks SS, Severijnen L, Mulder I, et al. Preventive treatment of intranasal fluticasone propionate reduces cytokine mRNA expressing cells before and during single nasal allergen provocation. Clin Exp Allergy 2000;30:1476-85.
42. Seeto C, Namkung-Matthai H, Jayrams S, Foe K, Brown KF, Hughes JM, et al. Differential potency of beclomethasone esters in-vitro on human T-lymphocyte cytokine production and osteoblast activity. J Pharm Pharmacol 2000;52: 417-23.
43. Hoiby N, Frederiksen B. Microbiology of cystic fibrosis. In: Hodson ME, Geddes DM, editors. Cystic Fibrosis. London: Arnold, 2000:83-108.
44. Polgar GE, Promadhat V. Pulmonary function testing in children: Techniques and standards. Philadelphia: W.B. Saunders, 1971:88-107.
45. Filip C, Fletcher G, Wulff JL, Earhart CF. Solubilisation of the cytoplasmic membrane of Escherichia coli by the ionic detergent sodium lauroyl sarcosinate. J Bacteriol 1973;115:717-22.
46. Shand GH, Anwar H, Kadurugamuwa J, Brown MRW, Silverman SH, Melling J. In vivo evidence that bacteria in urinary tract infection grow under iron-restricted conditions. Infect Immun 1985;48:35-9.
47. Kurtzhals JAL, Hansen MB, Hey AS, Poulsen LK. Measurement of antigen-dependent interleukin-4 production by human peripheral blood mononuclear cells. J Immunol Methods 1992;156: 239-45.
48. Murray JS. How the MHC selects Th1/Th2 immunity. Immunol Today 1998;19:157-63.
49. Romagnani S. The Th1/Th2 paradigm. Immunol Today 1997;18:263-6.
50. Constant SL, Bottomly K. Induction of TH1 and TH2 CD4+ T cell responses: the alternative approaches. Annu Rev Immunol 1997;15:297-322.
51. Constant SL, Lee KS, Bottomly K. Site of antigen delivery can influence T cell priming: pulmonary environment promotes preferential Th2-type differentiation. Eur J Immunol 2000;30: 840-7.
52. Stumbles PA, Thomas JA, Pimm CL, Lee PT, Venaille TJ, Proksch S, et al. Resting respiratory tract dendritic cells preferentially stimulate T helper cell type 2 (Th2) responses and require obligatory cytokine signals for induction of Th1 immunity. J Exp Med 1998;188:2019-31.
53. Welte K, Gabrilove J, Bronchud MH, Platzer E, Morstyn G. Filgrastim (r-metHuG-CSF): the first 10 years. Blood 1996;88:1907-29.
54. Boneberg EM, Hareng L, Gantner F, Wendel A, Hartung T. Human monocytes express functional receptors for granulocyte colony-stimulating factor that mediate suppression of monokines and interferon-γ. Blood 2000;95:270-6.
55. Galati G, Rovere P, Citterio G, Bondanza A, Scaglietti U, Bucci E, et al. In vivo administration of GM-CSF promotes the clearance of apoptotic cells: effects on monocytes and polymorphonuclear leukocytes. J Leukoc Biol 2000;67:174-82.
56. Aggarwal A, Baker CS, Evans TW, Haslam PL. G-CSF and IL-8 but not GM-CSF correlate with severity of pulmonary neutrophilia in acute respiratory distress syndrome. Eur Resp J 2000; 15:895-901.
57. Boey H, Rosenbaum R, Castracane J, Borish L. Interleukin-4 is a neutrophil activator. J Allergy Clin Immunol 1989;83:978-84.